[Guidelines of 19 March 2015 on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use]
从仂于仂亟于舒 仗仂 仂仄舒仍亳亰仂于舒仆仆仂亶 仂亠仆从亠 亳从仂于, 亟仂仂于亠ム亠亶 仂弍仍ミ莞黍出湖 仆舒亟仍亠亢舒亠亶 仗仂亳亰于仂亟于亠仆仆仂亶 仗舒从亳从亳 于仗仂仄仂亞舒亠仍仆 于亠亠于 仍亠从舒于亠仆仆 仗亠仗舒舒仂于 亟仍 仄亠亟亳亳仆从仂亞仂 仗亳仄亠仆亠仆亳
[Regulation (EC) No 726/2004 of The European Parliament and of The Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency]
亠亞仍舒仄亠仆 (EC) 726/2004 于仂仗亠亶从仂亞仂 仗舒仍舒仄亠仆舒 亳 弌仂于亠舒 仂 31 仄舒舒 2004 亞., 亰舒从仍舒亟于舒ム亳亶 仗仂亠亟 弌仂仂弍亠于舒 仗仂 亠亞亳舒亳亳 亳 仆舒亟亰仂 仍亠从舒于亠仆仆 仗亠仗舒舒仂于 亟仍 仄亠亟亳亳仆从仂亞仂 亳 于亠亠亳仆舒仆仂亞仂 仗亳仄亠仆亠仆亳 亳 亠亢亟舒ム亳亶 于仂仗亠亶从仂亠 舒亞亠仆于仂 仗仂 仍亠从舒于亠仆仆仄 亠亟于舒仄
[Guidelines of 19 March 2015 on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use]
从仂于仂亟于舒 仗仂 仂仄舒仍亳亰仂于舒仆仆仂亶 仂亠仆从亠 亳从仂于, 亟仂仂于亠ム亠亶 仂弍仍ミ莞黍出湖 仆舒亟仍亠亢舒亠亶 仗仂亳亰于仂亟于亠仆仆仂亶 仗舒从亳从亳 于仗仂仄仂亞舒亠仍仆 于亠亠于 仍亠从舒于亠仆仆 仗亠仗舒舒仂于 亟仍 仄亠亟亳亳仆从仂亞仂 仗亳仄亠仆亠仆亳
[Regulation (EC) No 726/2004 of The European Parliament and of The Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency]
亠亞仍舒仄亠仆 (EC) 726/2004 于仂仗亠亶从仂亞仂 仗舒仍舒仄亠仆舒 亳 弌仂于亠舒 仂 31 仄舒舒 2004 亞., 亰舒从仍舒亟于舒ム亳亶 仗仂亠亟 弌仂仂弍亠于舒 仗仂 亠亞亳舒亳亳 亳 仆舒亟亰仂 仍亠从舒于亠仆仆 仗亠仗舒舒仂于 亟仍 仄亠亟亳亳仆从仂亞仂 亳 于亠亠亳仆舒仆仂亞仂 仗亳仄亠仆亠仆亳 亳 亠亢亟舒ム亳亶 于仂仗亠亶从仂亠 舒亞亠仆于仂 仗仂 仍亠从舒于亠仆仆仄 亠亟于舒仄